Literature DB >> 3526352

Human parathyroid antigen: characterization and localization with monoclonal antibodies.

W G Cance, S A Wells, W G Dilley, M J Welch, F L Otsuka, J M Davie.   

Abstract

A cell surface antigen on human parathyroid cells was identified by monoclonal antibodies. The antigen, called parathyroid antigen (PTA), is found on both of two major polypeptides (190 kDa and 160 kDa) apparently associated exclusively with parathyroid cells. To determine whether PTA was a suitable target for in vivo imaging, 125I-labeled anti-PTA was injected into nude mice bearing human parathyroid xenografts. IgG1 anti-PTA antibody showed excellent radiolocalization of the grafts, whereas IgM anti-PTA, containing the same variable domains as the IgG1 antibody, showed little specific binding. These results suggest that antibody isotype is an important parameter for the in vivo immunoscintigraphy of specific cellular antigens.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3526352      PMCID: PMC386449          DOI: 10.1073/pnas.83.16.6112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  The in vivo localization of anti-Wagner-osteogenic-sarcoma antibodies.

Authors:  D PRESSMAN; L KORNGOLD
Journal:  Cancer       Date:  1953-05       Impact factor: 6.860

2.  Preparation of viable isolated bovine parathyroid cells.

Authors:  E M Brown; S Hurwitz; G D Aurbach
Journal:  Endocrinology       Date:  1976-12       Impact factor: 4.736

3.  Surface-specific iodination of membrane proteins of viruses and eucaryotic cells using 1,3,4,6-tetrachloro-3alpha,6alpha-diphenylglycoluril.

Authors:  M A Markwell; C F Fox
Journal:  Biochemistry       Date:  1978-10-31       Impact factor: 3.162

4.  Isolation of variants of mouse myeloma X63 that express changed immunoglobulin class.

Authors:  A Radbruch; B Liesegang; K Rajewsky
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

5.  Distribution of IgM monoclonal antibody in mice with human tumour xenografts: lack of tumour localization.

Authors:  M V Pimm; R W Baldwin
Journal:  Eur J Cancer Clin Oncol       Date:  1985-06

Review 6.  Selection of hybridomas and hybridoma variants using the fluorescence activated cell sorter.

Authors:  J L Dangl; L A Herzenberg
Journal:  J Immunol Methods       Date:  1982       Impact factor: 2.303

7.  Isolation and partial characterization of secretory protein I from bovine parathyroid glands.

Authors:  D V Cohn; J J Morrissey; J W Hamilton; R E Shofstall; F L Smardo; L L Chu
Journal:  Biochemistry       Date:  1981-07-07       Impact factor: 3.162

8.  Radioimmunoimaging of human small cell lung carcinoma with I-131 tumor specific monoclonal antibody.

Authors:  A M Zimmer; S T Rosen; S M Spies; M R Polovina; J D Minna; W C Spies; E A Silverstein
Journal:  Hybridoma       Date:  1985

9.  Tumor localization of Lewis lung carcinoma with radiolabeled monoclonal antibodies.

Authors:  P Midoux; T Maillet; F Thérain; M Monsigny; A C Roche
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

10.  Importance of immunoglobulin isotype in human antibody-dependent, cell-mediated cytotoxicity directed by murine monoclonal antibodies.

Authors:  T J Kipps; P Parham; J Punt; L A Herzenberg
Journal:  J Exp Med       Date:  1985-01-01       Impact factor: 14.307

View more
  2 in total

1.  Monoclonal antiparathyroid antibodies revealing defect expression of a calcium receptor mechanism in hyperparathyroidism.

Authors:  C Juhlin; G Akerström; L Klareskog; E Gylfe; H Johansson; R Larsson; S Ljunghall; P Nygren; J Rastad
Journal:  World J Surg       Date:  1988-08       Impact factor: 3.352

2.  Monoclonal antibodies with exclusive reactivity against parathyroid cells and tubule cells of the kidney.

Authors:  C Juhlin; R Holmdahl; H Johansson; J Rastad; G Akerström; L Klareskog
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.